Anxian Yuan China Holdings (HKG:922) Full Year 2025 Results

Key Financial Results

• Revenue: HK$236.4m (down 17% from FY 2024).
• Net income: HK$51.1m (down 12% from FY 2024).
• Profit margin: 22% (up from 20% in FY 2024). The increase in margin was driven by lower expenses.
• EPS: HK$0.023 (down from HK$0.026 in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

In the last 12 months, the only revenue segment was Cemetery Business contributing HK$236.4m. The largest operating expense was General & Administrative costs, amounting to HK$79.6m (65% of total expenses). Explore how 922's revenue and expenses shape its earnings.

Anxian Yuan China Holdings shares are down 1.7% from a week ago.

Risk Analysis

It is worth noting though that we have found 3 warning signs for Anxian Yuan China Holdings (1 is a bit unpleasant!) that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.